Canada & Coalition for Epidemic Preparedness Innovations

Canada: Canada>>> has imposed a 90-day entry ban on residents from the Democratic Republic of the Congo>>>, Uganda>>>, and South Sudan>>> due to concerns about the Ebola outbreak.

Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations (CEPI) is funding three groups, including Moderna and the University of Oxford, to accelerate the development of vaccines against the Bundibugyo strain of Ebola.

Canada: Approved Moderna's vaccine trial and imposed entry restrictions on travelers from DRC. Its regulatory support is important for vaccine development.

Coalition for Epidemic Preparedness Innovations: Funding vaccine development efforts, including the Oxford and Hilleman candidates. Its investment is critical for accelerating vaccine research.

Canada: Canada is an existing market for MVA-BN (IMVAMUNE); the EU approval does not directly affect its regulatory status but reinforces the vaccine's international availability.

Coalition for Epidemic Preparedness Innovations: CEPI co-funded the Phase 2 study supporting the approval; this aligns with its mission to accelerate vaccine development, though it has no direct financial stake.

Canada: Canada is mentioned as a co-host of the World Cup, which the Democratic Republic of the Congo football team cancelled its training camp for due to the Ebola outbreak.

Coalition for Epidemic Preparedness Innovations: CEPI is listed as a partner in the urgent coordination meeting convened by Africa CDC, indicating potential involvement in the response to the Ebola outbreak.